|
1
|
Acebron SP, Karaulanov E, Berger BS, Huang
YL and Niehrs C: Mitotic wnt signaling promotes protein
stabilization and regulates cell size. Mol Cell. 54:663–674. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Atlasi Y, Noori R, Gaspar C, Franken P,
Sacchetti A, Rafati H, Mahmoudi T, Decraene C, Calin GA, Merrill BJ
and Fodde R: Wnt signaling regulates the lineage differentiation
potential of mouse embryonic stem cells through Tcf3
down-regulation. PLoS Genet. 9:e10034242013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Esen E, Chen J, Karner CM, Okunade AL,
Patterson BW and Long F: WNT-LRP5 signaling induces Warburg effect
through mTORC2 activation during osteoblast differentiation. Cell
Metab. 17:745–755. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Clevers H: Wnt/beta-catenin signaling in
development and disease. Cell. 127:469–480. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Angers S and Moon RT: Proximal events in
Wnt signal transduction. Nat Rev Mol Cell Biol. 10:468–477. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Clevers H, Loh KM and Nusse R: Stem cell
signaling. An integral program for tissue renewal and regeneration:
Wnt signaling and stem cell control. Science. 346:12480122014.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Anastas JN and Moon RT: WNT signalling
pathways as therapeutic targets in cancer. Nat Rev Cancer.
13:11–26. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lang CMR, Chan CK, Veltri A and Lien WH:
Wnt signaling pathways in keratinocyte carcinomas. Cancers (Basel).
11:12162019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lee Y, Lee JK, Ahn SH, Lee J and Nam DH:
WNT signaling in glioblastoma and therapeutic opportunities. Lab
Invest. 96:137–150. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Milovanovic T, Planutis K, Nguyen A, Marsh
JL, Lin F, Hope C and Holcombe RF: Expression of Wnt genes and
frizzled 1 and 2 receptors in normal breast epithelium and
infiltrating breast carcinoma. Int J Oncol. 25:1337–1342.
2004.PubMed/NCBI
|
|
11
|
Benhaj K, Akcali KC and Ozturk M:
Redundant expression of canonical Wnt ligands in human breast
cancer cell lines. Oncol Rep. 15:701–707. 2006.PubMed/NCBI
|
|
12
|
Zheng W, Yao M, Fang M, Pan L, Wang L,
Yang J, Dong Z and Yao D: Oncogenic Wnt3a: A candidate specific
marker and novel molecular target for hepatocellular carcinoma. J
Cancer. 10:5862–5873. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kaur N, Chettiar S, Rathod S, Rath P,
Muzumdar D, Shaikh ML and Shiras A: Wnt3a mediated activation of
Wnt/β-catenin signaling promotes tumor progression in glioblastoma.
Mol Cell Neurosci. 54:44–57. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Jing Q, Li G, Chen X, Liu C, Lu S, Zheng
H, Ma H, Qin Y, Zhang D, Zhang S, et al: Wnt3a promotes
radioresistance via autophagy in squamous cell carcinoma of the
head and neck. J Cell Mol Med. 23:4711–4722. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
He S, Lu Y, Liu X, Huang X, Keller ET,
Qian CN and Zhang J: Wnt3a: Functions and implications in cancer.
Chin J Cancer. 34:554–562. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Verras M, Brown J, Li X, Nusse R and Sun
Z: Wnt3a growth factor induces androgen receptor-mediated
transcription and enhances cell growth in human prostate cancer
cells. Cancer Res. 64:8860–8866. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Grumolato L, Liu G, Mong P, Mudbhary R,
Biswas R, Arroyave R, Vijayakumar S, Economides AN and Aaronson SA:
Canonical and noncanonical Wnts use a common mechanism to activate
completely unrelated coreceptors. Genes Dev. 24:2517–2530. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Katoh M: Canonical and non-canonical WNT
signaling in cancer stem cells and their niches: Cellular
heterogeneity, omics reprogramming, targeted therapy and tumor
plasticity (Review). Int J Oncol. 51:1357–1369. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Klaus A and Birchmeier W: Wnt signalling
and its impact on development and cancer. Nat Rev Cancer.
8:387–398. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Polakis P: The many ways of Wnt in cancer.
Curr Opin Genet Dev. 17:45–51. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Reya T and Clevers H: Wnt signalling in
stem cells and cancer. Nature. 434:843–850. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Duchartre Y, Kim YM and Kahn M: The Wnt
signaling pathway in cancer. Crit Rev Oncol Hematol. 99:141–149.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Polakis P: Wnt signaling and cancer. Genes
Dev. 14:1837–1851. 2000.PubMed/NCBI
|
|
24
|
Corda G and Sala A: Non-canonical WNT/PCP
signalling in cancer: Fzd6 takes centre stage. Oncogenesis.
6:e3642017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kurayoshi M, Oue N, Yamamoto H, Kishida M,
Inoue A, Asahara T, Yasui W and Kikuchi A: Expression of Wnt-5a is
correlated with aggressiveness of gastric cancer by stimulating
cell migration and invasion. Cancer Res. 66:10439–10448. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Weeraratna AT, Jiang Y, Hostetter G,
Rosenblatt K, Duray P, Bittner M and Trent JM: Wnt5a signaling
directly affects cell motility and invasion of metastatic melanoma.
Cancer Cell. 1:279–288. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Vander Heiden MG, Cantley LC and Thompson
CB: Understanding the Warburg effect: The metabolic requirements of
cell proliferation. Science. 324:1029–1033. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Warburg O: On the origin of cancer cells.
Science. 123:309–314. 1956. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Cairns RA, Harris IS and Mak TW:
Regulation of cancer cell metabolism. Nat Rev Cancer. 11:85–95.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hsu PP and Sabatini DM: Cancer cell
metabolism: Warburg and beyond. Cell. 134:703–707. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Pate KT, Stringari C, Sprowl-Tanio S, Wang
K, TeSlaa T, Hoverter NP, McQuade MM, Garner C, Digman MA, Teitell
MA, et al: Wnt signaling directs a metabolic program of glycolysis
and angiogenesis in colon cancer. EMBO J. 33:1454–1473. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lee SY, Jeon HM, Ju MK, Kim CH, Yoon G,
Han SI, Park HG and Kang HS: Wnt/Snail signaling regulates
cytochrome C oxidase and glucose metabolism. Cancer Res.
72:3607–3617. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Mor I, Cheung EC and Vousden KH: Control
of glycolysis through regulation of PFK1: Old friends and recent
additions. Cold Spring Harb Symp Quant Biol. 76:211–216. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Moreno-Sanchez R, Rodriguez-Enriquez S,
Marin-Hernandez A and Saavedra E: Energy metabolism in tumor cells.
FEBS J. 274:1393–1418. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Dunaway GA and Kasten TP: Nature of the
subunits of the 6-phosphofructo-1-kinase isoenzymes from rat
tissues. Biochem J. 242:667–671. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Kahn A, Meienhofer MC, Cottreau D,
Lagrange JL and Dreyfus JC: Phosphofructokinase (PFK) isozymes in
man. I. Studies of adult human tissues. Hum Genet. 48:93–108. 1979.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Lee JH, Liu R, Li J, Zhang C, Wang Y, Cai
Q, Qian X, Xia Y, Zheng Y, Piao Y, et al: Stabilization of
phosphofructokinase 1 platelet isoform by AKT promotes
tumorigenesis. Nat Commun. 8:9492017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Lee JH, Liu R, Li J, Wang Y, Tan L, Li XJ,
Qian X, Zhang C, Xia Y, Xu D, et al: EGFR-Phosphorylated platelet
isoform of phosphofructokinase 1 promotes PI3K activation. Mol
Cell. 70:197–210.e7. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Lee JH, Shao F, Ling J, Lu S, Liu R, Du L,
Chung JW, Koh SS, Leem SH, Shao J, et al: Phosphofructokinase 1
platelet isoform promotes β-catenin transactivation for tumor
development. Front Oncol. 10:2112020. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Stine ZE and Dang CV: Stress eating and
tuning out: Cancer cells re-wire metabolism to counter stress. Crit
Rev Biochem Mol Biol. 48:609–619. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Rider MH, Bertrand L, Vertommen D, Michels
PA, Rousseau GG and Hue L:
6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase: Head-to-head
with a bifunctional enzyme that controls glycolysis. Biochem J.
381((Pt 3)): 561–579. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Cancer Genome Atlas Research Network, .
Comprehensive genomic characterization defines human glioblastoma
genes and core pathways. Nature. 455:1061–1068. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Avraham R and Yarden Y: Feedback
regulation of EGFR signalling: Decision making by early and delayed
loops. Nat Rev Mol Cell Biol. 12:104–117. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Prenzel N, Zwick E, Daub H, Leserer M,
Abraham R, Wallasch C and Ullrich A: EGF receptor transactivation
by G-protein-coupled receptors requires metalloproteinase cleavage
of proHB-EGF. Nature. 402:884–888. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Blobel CP: ADAMs: Key components in EGFR
signalling and development. Nat Rev Mol Cell Biol. 6:32–43. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Ohtsu H, Dempsey PJ and Eguchi S: ADAMs as
mediators of EGF receptor transactivation by G protein-coupled
receptors. Am J Physiol Cell Physiol. 291:C1–C10. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Roelle S, Grosse R, Aigner A, Krell HW,
Czubayko F and Gudermann T: Matrix metalloproteinases 2 and 9
mediate epidermal growth factor receptor transactivation by
gonadotropin-releasing hormone. J Biol Chem. 278:47307–47318. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Koval A and Katanaev VL: Wnt3a stimulation
elicits G-protein-coupled receptor properties of mammalian Frizzled
proteins. Biochem J. 433:435–440. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Nichols AS, Floyd DH, Bruinsma SP,
Narzinski K and Baranski TJ: Frizzled receptors signal through G
proteins. Cell Signal. 25:1468–1475. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Yang-Snyder J, Miller JR, Brown JD, Lai CJ
and Moon RT: A frizzled homolog functions in a vertebrate Wnt
signaling pathway. Curr Biol. 6:1302–1306. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Schlange T, Matsuda Y, Lienhard S, Huber A
and Hynes NE: Autocrine WNT signaling contributes to breast cancer
cell proliferation via the canonical WNT pathway and EGFR
transactivation. Breast Cancer Res. 9:R632007. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Civenni G, Holbro T and Hynes NE: Wnt1 and
Wnt5a induce cyclin D1 expression through ErbB1 transactivation in
HC11 mammary epithelial cells. EMBO Rep. 4:166–171. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Sanchez-Martinez C and Aragon JJ: Analysis
of phosphofructokinase subunits and isozymes in ascites tumor cells
and its original tissue, murine mammary gland. FEBS Lett.
409:86–90. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Moon JS, Kim HE, Koh E, Park SH, Jin WJ,
Park BW, Park SW and Kim KS: Kruppel-like factor 4 (KLF4) activates
the transcription of the gene for the platelet isoform of
phosphofructokinase (PFKP) in breast cancer. J Biol Chem.
286:23808–23816. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Wang G, Xu Z, Wang C, Yao F, Li J, Chen C
and Sun S: Differential phosphofructokinase-1 isoenzyme patterns
associated with glycolytic efficiency in human breast cancer and
paracancer tissues. Oncol Lett. 6:1701–1706. 2013. View Article : Google Scholar : PubMed/NCBI
|
